Newbridge Financial Services Group Inc. Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Newbridge Financial Services Group Inc. trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,220 shares of the healthcare conglomerate’s stock after selling 40 shares during the quarter. Newbridge Financial Services Group Inc.’s holdings in UnitedHealth Group were worth $617,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in UNH. International Assets Investment Management LLC lifted its stake in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. grew its stake in UnitedHealth Group by 9,235.4% during the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after buying an additional 776,516 shares during the period. Raymond James & Associates lifted its holdings in shares of UnitedHealth Group by 33.1% during the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec raised its position in UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after purchasing an additional 581,324 shares during the period. Finally, State Street Corp grew its stake in shares of UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Down 0.6 %

UnitedHealth Group stock opened at $526.68 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a 50-day simple moving average of $529.18 and a 200-day simple moving average of $564.30. The firm has a market capitalization of $484.69 billion, a P/E ratio of 33.98, a P/E/G ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on UNH shares. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.